Bifonazole
SIGMA/B3563 - ≥98% (HPLC)
Synonym: 1-(p,α-Diphenylbenzyl)imidazole
CAS Number: 60628-96-8
Empirical Formula (Hill Notation): C22H18N2
Molecular Weight: 310.39
EC Number: 262-336-6
MDL Number: MFCD00865567
Linear Formula: C22H18N2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C22H18N2/c1-3-7-18(8-4 |
| InChI key | OCAPBUJLXMYKEJ-UHFFFAOYSA |
| originator | Bayer |
| Quality Level | 100 ![]() |
| SMILES string | c1ccc(cc1)C(c2ccc(cc2)-c3 |
| solubility | DMSO: >10 mg/mL |
| storage temp. | room temp |
| Biochem/physiol Actions: | Bifonazole is an imidazole-based anti-fungal agent with broad spectrum activity against many fungi, molds, yeast and some Gram-positive bacteria. Bifonazole inhibits ergosterol biosynthetic protein 28 and Cytochrome P450 2B4. |
| Biochem/physiol Actions: | Bifonazole is used to treat several infections such as onychomycoses, otomycoses, erythrasma, psoriasis, sebopsoriasis, seborrhoeic dermatitis and rosacea. Bifonazole is also used as an important drug to treat melanoma. |
| Features and Benefits: | This compound was developed by Bayer . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


